What'sNearbyTM

What are you looking for?

Close Search
      We apologize for the inconvenience

      The people search feature on Superpages.com is temporarily unavailable. You can still search for people on yellowpages.com since Yellow Pages and Superpages are part of one company.

      You will be automatically re-directed to People Search on yellowpages.com in .

      Please note our privacy policy has changed. To view the policy, please go to https://corporate.thryv.com/privacy/

      Details

      General Info

      Regenerative Medical Solutions (RMS) is a biotechnology company focused on transforming diabetes treatment through innovative stem cell technology. Based in Madison, WI, RMS specializes in developing stem cell-derived Islet-Like Clusters (ILCs) for both continued research purposes and therapeutic applications. Our proprietary technology, developed over 15 years of research, enables scalable production of ILCs that function like human pancreatic islet cells, offering new hope for diabetes treatment. RMS is dedicated to advancing diabetes care through cutting-edge research, product development, and clinical solutions.

      HoursCLOSED NOW
      Regular Hours:
      Mon - Fri
      Sat - SunClosed

      Contact Info

      Phone:

      Main - 312-725-6450

      Address:
      505 S Rosa Rd Ste 26 Madison, WI 53719
      Link:

      https://www.regenmedsolutions.com/contact-alternative

      Reviews

      Be the first to review!
      Write a Review
      Categories
      Medical Information & Research, Physicians & Surgeons
      Services / Products
      Allogeneic ILC Cellular Therapeutics – Stem cell therapy using donor-derived iPSCs to treat diabetes Cell Therapy Development – Advancing autologous and allogeneic stem cell therapies for diabetes Clinical Trial Preparation – Pre-clinical development for cellular therapeutics targeting diabetes. Diabetes Research Tools – Offering ILC cells for in vitro studies, drug research, and toxicity tests ILC Cell Technology – Human iPSC-derived Islet-Like Clusters (ILCs) for research. ILC Cells Kit – Cryopreserved single-cell ILCs for diabetes research, discovery, and toxicity tests. ILC Cellular Therapeutics – Stem cell-based therapeutic candidates in pre-clinical development. Stem Cell Differentiation – Developing proprietary methods to create pancreatic islet-like cells
      Associations
      Northwestern University: Advisor Harry M. Jansen Kraemer, Jr., is a Clinical Professor,University of California, San Francisco (UCSF): Advisor Dr. Peter G. Stock,University of Wisconsin-Madison: Collaborates with stem cell pioneer Dr. James Thomson
      Provided by
      Data provided by one or more of the following: Thryv, Data Axle, Yext.